The reference diagnostic test to detect fibrosis is liver biopsy (LB), a procedure subject to various limitations, including risk of patient injury and sampling error. FibroTest (FT) and ActiTest (AT) are biochemical markers (noninvasive tests) used in determining the level of fibrosis and the degree of necroinflammatory activity in the liver. The objective of this work is to discover the differences in the temporal patterns between noninvasive tests and liver biopsy by visualization tools, which made it easier to understand the relations of the complicated rules. This Study ware focused on the major serum fibrosis markers (FT/AT). The test uses a combination of serum biochemical markers with visualization technique to evaluate whether biochemical markers can be used to estimate the stage of liver fibrosis and necro-inflammatory activity in the liver.
Copyrights (c) 2012 Computer Science Journals. All rights reserved.
Best viewed at 1152 x 864 resolution. Microsoft Internet Explorer.
Copyrights & Usage: Articles published by CSC Journals are Open Access. Permission to copy and distribute any other content, images, animation and other parts of this website is prohibited. CSC Journals has the rights to take action against individual/group if they are found victim of copying these parts of the website.